baber/WOPTO huggingface dataset:
Patent NZ-267449-A (NZ)
Title: Suspended solids and/or fluid droplets separated from liquid with conical helical plates
Inventor: DE HOXAR DAVID AUSTEN
IPC: B01D21/00
Filed: 1994-06-17
Abstract: PCT No. PCT/GB94/01311 Sec. 371 Date Feb. 28, 1995 Sec. 102(e) Date Feb. 28, 1995 PCT Filed Jun. 17, 1994 PCT Pub. No. WO95/01215 PCT Pub. Date Jan. 12, 1995A method and apparatus for separating suspended solid particles and/or fluid droplets from a body of liquid is described. Fluid is caused to flow through at least one helical flow path defined between axially facing surfaces of a number of conical helical plates. Preferably, a substantially vertical flow channel of circular cross-section has disposed therein at least one conical helical plate with a diameter substantially equal to that of the flow channel. The conical helical plate or plates are arranged coaxially in the flow channel and define at least one helical flow path coaxial with the flow channel between axially facing surfaces of the plate or plates. The plate or plates are preferably capable of rotating about the axis of the flow channel, and may be driven. While they may be driven at a greater or lesser speed, they are preferably driven at a speed so as to approximately correspond with the flow rate of the liquid.
Patent NZ-268891-A (NZ)
Title: Arylthioalkylthiopyridines; compounds, preparation and medicaments
Inventor: KOHL BERNHARD
IPC: A61P31/04
Filed: 1994-06-28
Abstract: PCT No. PCT/EP95/02098 Sec. 371 Date Dec. 20, 1995 Sec. 102(e) Date Dec. 20, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01351 PCT Pub. Date Jan. 12, 1995Described are compounds of formula (I) in which R1,R2,R3,R4,R5,R6,R7, m,n,p, and q are as defined in the description. Such compounds are suitable for use against Helicobacter bacteria.    <IMAGE>  (I)
Patent NZ-275075-A (NZ)
Title: Clarifying fruit juice: raw juice fed to membrane filter at constant flow rate and then constant pressure while retentate recirculated by positive-displacement pump
Inventor: HARTMANN EDUARD
IPC: B01D61/20
Filed: 1994-11-17
Abstract: PCT No. PCT/CH94/00221 Sec. 371 Date Jul. 26, 1995 Sec. 102(e) Date Jul. 26, 1995 PCT Filed Nov. 17, 1994 PCT Pub. No. WO95/15209 PCT Pub. Date Jun. 8, 1995To thicken retentate residues using ultra- or microfiltration to clarify fruit juices, apparatuses which have membrane modules (1, 2) are used in the cross-flow process with a retentate circuit. It is proposed that first, the process be carried out with virtually constant retentate overflow velocity at the membranes until there is an increased concentration. Then the transmembrane pressure of membrane modules (1, 2) is kept constant or further increased, and the overflow velocity is reduced, until the desired thickening of the retentate residue is achieved. So that the last reduction step can be carried out, speed-governed retentate displacement pumps (8) are employed. To prevent stoppages of the membranes of membrane modules (1, 2), the apparatus is operated with special flow dividers (10) for the retentate, or an individual circulating pump is associated with each group of membrane modules.
Patent NZ-279868-A (NZ)
Title: Fish hook, resilient hook-closing element held in open position by slidable detent
Inventor: VAN DER HOVEN NICOLAAS PHILLIP
IPC: A01K83/00
Filed: 1995-02-21
Abstract: A fish hook comprises a shank 12 terminating at one end in a barbed hook formation 14 and at the other end in a head 16. A hook-closing element 18 which is of resiliently flexible steel wire is mounted on the head 16 and is displaceable between a retracted position in which it lies adjacent the shank, and an extended position in which it extends across the gap between the shank and the tip of the hook formation. A detent pin 28 holds the hook-closing element in the retracted position. When the detent pin is pulled, the hook-closing element is released so that it moves, under action of its bias, from the retracted to the extended position.
Patent NZ-284295-A (NZ)
Title: Use of bisphosphonates to treat periprosthetic bone resorption
Inventor: YATES ASHLEY J
IPC: A61K31/675
Filed: 1995-04-17
Abstract: Treatment and preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.
Patent NZ-296648-A (NZ)
Title: Nematode-extracted serine protease inhibitors and anticoagulant proteins
Inventor: VLASUK GEORGE PHILLIP
IPC: A61K35/56
Filed: 1995-10-17
Abstract: Proteins that have activity as anticoagulants and/or serine protease inhibitors and have at least one NAP can be isolated from natural sources as nematodes, chemically synthesized or made by recombinant methods using various DNA expression systems. Certain of these proteins have factor Xa inhibitory activity and others have activity as inhibitors of factor VIIa/TF.
Patent NZ-297572-A (NZ)
Title: Inhalation air humidifier and regenerative heat exchanger comprising a humidifier having a casing connected to a moisture-heat exchanger unit
Inventor: NILSON BILLY
IPC: A61M16/10
Filed: 1995-11-30
Abstract: PCT No. PCT/SE95/01444 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Nov. 30, 1995 PCT Pub. No. WO96/16689 PCT Pub. Date Jun. 6, 1996A moisture-heat exchange arrangement which is intended for connection to a patient to humidify and heat the air inhaled by the patient, wherein the arrangement includes a moisture-heat exchanger unit (5) and a humidifier means (11, 12) that connects with the unit (5) to increase the humidity of the inhalation air. The humidifying means includes a casing (3) which is connected with the moisture-heat exchanger unit (5) and which has a first opening (9) that communicates with the moisture-heat exchanger unit and an opposing opening (6) that communicates with the patient. The inner surface of the casing has provided thereon a water-absorbing and/or water-vapour permeable material (11) which delivers moisture to the air inhaled by the patient.
Patent NZ-298755-A (NZ)
Title: Process for preparation of fuel grade dimethyl ether from synthesis gas by conversion of the synthesis gas into a mixed process gas of dimethyl ether , methanol and water
Inventor: VOSS BODIL
IPC: C07C41/09
Filed: 1996-01-29
Abstract: PCT No. PCT/DK96/00047 Sec. 371 Date Dec. 12, 1997 Sec. 102(e) Date Dec. 12, 1997 PCT Filed Jan. 29, 1996 PCT Pub. No. WO96/23755 PCT Pub. Date Aug. 8, 1996A process for the preparation of dimethyl ether. The process prepares fuel grade dimethyl ether from a hydrogen and carbon oxides synthesis gas.
Patent NZ-331857-A (NZ)
Title: Benzofuranone derivatives and process for producing the same
Inventor: YOSHIHAMA MAKOTO
IPC: A61P13/02
Filed: 1998-01-13
Abstract: A benzofuranone derivative of the formula is claimed wherein R1-R5 are independently H, OH, alkyl, alkoxy or aralkyloxy, halogen, amino or alkylene dioxy group joined at R1 and R2, R2 and R3, R3 and R4 and R5 and R6 OH, alkoxy, aralkyloxy or carboxylic acid ester limited by the provisos that i) R3 is not halogen when R6 is OH; ii) R3 is not OH when R6 is OH or alkoxy and iii) R3 is not alkoxy when R6 is alkoxy. A medicament containing the above compound useful for treating hormone dependent diseases is claimed.
Patent NZ-333356-A (NZ)
Title: Use of thyroxine analogues having no significant hormonal activity to treat malignant tumors
Inventor: KUN ERNEST
IPC: A61K31/216
Filed: 1997-05-30
Abstract: Thyroxine analogues having no significant hormonal activity and being a compound capable of causing 35% or more inhibition of initial velocity of microtubule protein assembly in vitro are used in a manufacture of a medicament for treating a malignant tumour in a mammal. The thyroxine analogue can have the formula I wherein: X is O, S, CH2 or carboxy or is absent; Y is O or S; R1 is methyl or ethyl; R2 to R4 are independently H, alkyl, alkenyl, alkynyl, OH, alkoxy or halogen; R6 to R9 are independently H, alkyl, alkenyl, alkynyl, OH, alkoxy, halogen, NO2 or NH2.
Patent NZ-333591-A (NZ)
Title: Thiazole compounds, process of manufacture and their use for treating prophylaxis and other diseases
Inventor: ALIG LEO
IPC: A61P35/04
Filed: 1998-12-24
Abstract: Thiazole derivatives of formula I which inhibit the binding of adhesive proteins such as fibrinogen, vitronectin, thrombospondin and osteopontin, to the vitronectin receptors on the surface of different types of cell where: R1 is selected from a, b or c R2 is d where Het is a 5-8 membered heterocyclic ring system which is substituted with R9 and an additional N, O or S atom can be present in the ring in addition to the nitrogen atom, R3 is H, alkyl, cycloalkyl, aryl, aralkyl or heteroaryl; R4 is H, alkyl, cycloalkyl, aryl, aralkyl or heteroaryl; R5, R6, R7 and R8 are each independently H, alkyl, cycloalkyl or R7 and R8 together with the N atoms to which they are attached form a 5-8 membered heterocyclic ring, optionally substituted by alkyl; R9 is e or f R10 is aryl, aralkyl, heterocyclyl, or an á-amino acid bonded via the amino group, a-i are 0 or positive numbers where a and b are 0-4 d is 0 or 1 f being equal to 0 when d is 0; the sum of c, d and e is = 1 and = 4, f and h are independently 0 or 1 with I being other than 0 when h=1, the sum of g, h and I is = 2 and =5; Pharmaceutical compositions containing said thiazole derivatives are described, and their use in treating neoplasm's, tumours and related diseases.
Patent NZ-334103-A (NZ)
Title: an expression vector used to transform or transfect a host cell to make a thrombopoietin polypeptide, the cultured yeast cell thereof and the thrombopoietin polypeptide
Inventor: IRANI MEHER
IPC: A61P7/00
Filed: 1997-07-30
Abstract: The expression vector replicable in a eukaryotic host cell comprises: a) a transcription promoter; b) a first DNA segment encoding a secretory leader; c) a second DNA segment encoding a thrombopoietin polypeptide backbone consisting of C-X-B, wherein C is a human thrombopoietin cytokine domain polypeptide; X is a peptide bond or a linker consisting of one or two amino acid residues, subject to the limitation that X, alone or in combination with C or B, does not provide a dibasic amino acid pair; and B is a polypeptide consisting of residues 1 to y of SEQ ID NO:3, wherein y is an integer from 5 to 18, and wherein up to 35 % of the amino acid residues of B are individually replaced by other amino acid residues and d) a transcription terminator. The polypeptides are characterized by an amino acid backbone consisting of C-X-B wherein: C is a human thrombopoietin cytokine domain polypeptide; X is a peptide bond or a linker consisting of one or two amino acid residues, subject to the limitation that X, alone or in combination with C or B, does not provide a dibasic amino acid pair; and B is a polypeptide consisting of residues 1 to y of SEQ ID NO:3, wherein y is an integer from 5 to 18, and wherein up to 35 % of the amino acid residues of B are individually replaced by other amino acid residues. The polypeptides are useful with methods of stimulating proliferation or development of hematopoietic cells in vitro and in vivo.
Patent NZ-337280-A (NZ)
Title: Continuous extrusion process using organic waste materials predominantly consisting of rice hull
Inventor: PAGDEN KENNETH LINDSAY
IPC: B29C48/475
Filed: 1998-02-11
Abstract: A substantially continuous method for forming a structural panel of indefinite length which comprises the following steps: (a) preparing a settable mixture including an organic particulate base material consisting predominantly of rice hull and a binder, (b) conveying the mixture in a flowable state to a load chamber, (c) progressively forcing the mixture from the load chamber through an inlet toward an outlet of an open ended mould chamber of constant cross section by compression means, (d) partially curing the mixture within the mould chamber, (e) resisting movement of the mixture through the mould chamber until a predetermined consolidation pressure or density within the mould chamber is achieved, (f) subsequently allowing movement of the mixture through the mould chamber in response to further mixture being first forced through the inlet by the compression means, (g) allowing the mixture to cure, and thereby progressively forming a structural panel of substantially indefinite length. An apparatus for forming said structural panel of indefinite length is also described.
Patent NZ-501075-A (NZ)
Title: (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate
Inventor: NYQVIST HAKAN
IPC: A61P25/28
Filed: 1998-05-15
Abstract: The salt (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate and the monohydrate form is provided.  The salt may be used in medicaments for treating 5-HT1A receptor antagonist activity related CNS disorders, such as urinary incontinence, depression and anxiety.
Patent NZ-502884-A (NZ)
Title: DNA and peptide sequences encoding the cytokine LERK-6 that bind to the hek or elk receptor
Inventor: CERRETTI DOUGLAS PAT
IPC: C12N1/19
Filed: 1998-08-27
Abstract: DNA sequences and polynucleotides of the cytokine LERK-6 that bind to the hek or elk receptor.  Also described are vectors, host cells, and processes for producing a LERK-6 polypeptide as well as antibodies to the polypeptide and the use of the polypeptide to make pharmaceuticals.  Further described are animals possessing a LERK-6 gene.
Patent NZ-508137-A (NZ)
Title: A lactic acid bacterial DNA vector containing a tRNA comprising an amber suppressor and a replicon to enable the vector to replicate in a lactic acid bacterium
Inventor: SOERENSEN KIM IB
IPC: C12N15/68
Filed: 1999-04-14
Abstract: Described are food-grade cloning vectors comprising a nonsense mutation suppressor-encoding gene.  This vector, when it is present in a lactic acid bacterial strain, permits the strain to have an industrially appropriate growth rate and metabolic activity.  The cloning vectors are useful when present in lactic acid bacteria used as starter cultures in the preparation of food or feed products, or a dairy flavour.
Patent NZ-517004-A (NZ)
Title: Sail of broadseamed laminated reinforced sections
Inventor: BAUDET JEAN-PIERRE
IPC: B63H9/06
Filed: 2000-09-08
Abstract: A sail body (3), which can be finished along its edges and corners to create a finished sail (2), includes a number of sail sections (46) joined along their edges. Each sail section includes a reinforcing material laminated between first and second films. The reinforcing material includes sectors 30 of reinforcing material, each sector having a set of generally parallel reinforcement elements, such as fibers and another set of reinforcing fibers oriented perpendicular to the first set of reinforcing fibers. The sectors of reinforcing material are preferably elongate sectors in which at least the majority of the sectors have lengths at least five times as long their widths. The sectors are arranged in an overlapping pattern so that the set of reinforcement elements are generally aligned with the expected load lines (28) for that section of the sail body. Moreover the first set of reinforcing fibers of one sector 38 lies at an acute angle to the first set of reinforcing fibers of an overlapping sector 40 of the pattern.  Sections can be made of different shapes but are typically triangular or quadrilateral. The reinforcing material is typically a mesh or scrim containing sets of parallel, transversely oriented fibers. The mesh or scrim can either be woven or unwoven.
Patent NZ-517777-A (NZ)
Title: Housing for a television camera such as a closed circuit camera
Inventor: ALESSIO GROTTO
IPC: H04N5/225
Filed: 2002-03-13
Abstract: A case for a television camera consisting of a container that has a planar base and a convex top that forms a cover for the base, the top being laterally hinged to close onto the lower part and able to be locked thereto when closed, the top having two ends with one end being closed and the other being a window.
Patent NZ-519395-A (NZ)
Title: Techniques for identifying genes that are important for virulence in Mycobacterial vaccines
Inventor: COLLINS DESMOND MICHAEL
IPC: C12Q1/18
Filed: 2002-06-07
Abstract: Attenuated strains of Mycobacterium tuberculosis complex, which comprise at least one inactive gene, are described. Also described are methods for producing and screening the attenuated strains, methods for assessing their vaccine potential and the use of such strains and derivatives thereof as vaccines against tuberculosis in humans and animal medical practice.
Patent NZ-522424-A (NZ)
Title: Wind power installation
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2001-03-02
Abstract: A wind power installation is disclosed. Modern wind power installations are regularly equipped with a lightning protection system. What is disclosed avoids drawbacks and, in particular, minimizes the number of disturbances to the electronics caused by sparkovers occurring on the spark gaps. The wind power installation comprises a device for continuously discharging electrostatic charge from at least one rotor blade of a wind power installation.
Patent NZ-523365-A (NZ)
Title: A utility metering system incorporating a transaction authorisation system
Inventor: JARMAN MICHAEL
IPC: G06Q20/34
Filed: 2001-05-18
Abstract: A transaction authorisation system comprises a user interface unit (30) capable of accepting a transaction authorisation and a utility meter (10) provided at a location having an associated location identifier unique to the location, wherein the utility meter (10) is arranged to communicate with the user interface unit (10), to obtain a transaction authorisation, and to transmit an authorisation request based on the transaction authorisation and location identifier to obtain authorisation of the transaction.
Patent NZ-524093-A (NZ)
Title: Marketing systems used to calculate benefits to customers based on customer identifiers, merchant identifier and customer behavior
Inventor: FOWLER MALCOLM R
IPC: G06Q30/00
Filed: 2001-08-22
Abstract: An automated marketing system implemented using a host controller system, comprises : acquiring a user identifier, a merchant identifier, and a user behavior identifier at a point of transaction and communicating each of the identifiers to a host controller system over a communications network; validating eligibility of at least one of the user identifier, the merchant identifier and the user behavior identifier to determine eligibility for participation in at least one marketing program; performing a rate calculation processing step to determine eligibility of the user, the merchant and the user behavior for an award based on a preselected set of criteria; and communicating information relating to delivery of an award or an updated award status condition to the point of transaction over a communications network.
Patent NZ-529303-A (NZ)
Title: Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
Inventor: MERCE-VIDAL RAMON
IPC: A61P37/08
Filed: 2002-03-21
Abstract: Azolylcarbynol derivatives of aryl (or heteroaryl) of formula (I) are disclosed, wherein Ar represents an optionally substituted phenyl or thyenyl radical; R1 represents a hydrogen atom or an inferior alkyl group; R2 represents a dialkylaminoalkyl or azaheterocyclilalkyl radical and Het represents a non-substituted azole or an azole optionally substituted by one or two substituents, and their physiologically acceptable salts. These derivatives are useful as medicaments in human and/or veterinary therapy for the treatment of respiratory diseases, more particularly for the treatment of coughing, bronchitis, chronic obstructive lung diseases, allergic rhinitis and asthma.
Patent NZ-529925-A (NZ)
Title: 3-fluoro-pyrrolidines as antidiabetic agents
Inventor: PITT GARY ROBERT WILLIAM
IPC: C07D417/12
Filed: 2002-06-24
Abstract: Disclosed are compounds formula 1, wherein: A is F or H, one of R1A and R1B is selected from H and CN and the other is H, R2 is selected from H, alkyl, optionally substituted phenyl, optionally substituted benzyl and R5, R3 is selected from H, alkyl, adamantly, adamantylmethyl, adamantylethyl and Het-NH(CH2)a, or R2 and R3 together constituted a chain of three or four methylene groups so as to form, together with the atoms to which they are attached, a pyrrolidine or piperidine ring, which may be further fused with a benzenoid ring, R4 is selected from H, R6OCO, H2NCH(R7)CO, H2NCH(R8)CONHCH(R9)CO, and a group of formula 2, and the remaining substituents are defined herein.
Patent NZ-537750-A (NZ)
Title: Film coating for tamper proof capsules
Inventor: CADE DOMINIQUE NICOLAS
IPC: A61K47/34
Filed: 2003-07-30
Abstract: A tamper-proof capsule is disclosed, which comprises at least one capsule shell part and enclosing a solid dosage form core, said core being coated with a coating composition comprising a film forming agent in an amount of from 0 to 85 % by weight, an adhesion enhancing agent in an amount of from 10 to 90 % by weight, and a glidant in an amount of from 5 to 50 % by weight, based on the weight of the coating composition.
Patent NZ-537864-A (NZ)
Title: Pharmaceutical compositions for buccal delivery of pain relief medications
Inventor: MODI PANKAJ
IPC: A61K31/4468
Filed: 2003-08-14
Abstract: A pharmaceutical composition for pain relief comprising: an effective amount of a narcotic analgesic in micellar form, an alkali metal alkyl sulfate, a polyoxyethylene ether or pharmaceutically acceptable salts thereof, and a solvent; said alkali metal alkyl sulfate and polyoxyethylene ether or its salt each present in a concentration of between about 0.1 and 30 wt. /wt. % of the total composition; and the total concentration of the alkali metal alkyl sulfate and polyoxyetbylene ether or its salt together is less than about 50 wt. /wt. % of the total composition.
Patent NZ-538535-A (NZ)
Title: Intermediates in producing phenoxyacetic acid derivatives and method of using the same
Inventor: TANAKA NOBUYUKI
IPC: C07C67/31
Filed: 2002-09-05
Abstract: Disclosed herein are intermediates represented by formula (I), which are useful in producing phenoxyacetic acid derivatives represented by formula (X) or pharmaceutically acceptable salts thereof having an effect of stimulating beta3-adrenalin receptor and being useful for the treatment or prevention of obesity, hyperglycemia, diseases caused by enteric movement disorders, urinary frequency, urinary incontinence, depression or biliary calculus; a process for producing these intermediates of formula (I); and a process for producing phenoxyacetic acid derivatives of formula (X), wherein each of R1 and R2 independently represent a lower alkyl group.
Patent NZ-540232-A (NZ)
Title: Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
Inventor: BAILEY STUART
IPC: C07C321/22
Filed: 2002-01-18
Abstract: Disclosed are phenylalanine enamide derivatives of formula (1) wherein: R1 is a group Ar1L2Alk- as defined in the specification; X is an -N(R2)- group wherein R2 is H or C1-6alkyl; V is O; Rx, Ry and Rz may be the same or different and each represent L1(Alk1)n(R3)v as defined in the specification; n is zero or 1; and v is 1, 2 or 3. Compounds of the type disclosed are selective inhibitors of alpha-4 integrins.
Patent NZ-541708-A (NZ)
Title: Virosome-like-particles
Inventor: HUCKRIEDE ANKE LUISE WILHELMIN
IPC: A61K39/39
Filed: 2004-02-11
Abstract: Disclosed is a method for producing a virosome-like-particle comprising: contacting an enveloped virus with a solution containing a short-chain phospholipid allowing solubilisation of the viral envelope of said virus; and removing the short-chain phospholipid from said solution allowing formation of a functionally reconstituted viral envelope.
Patent NZ-541825-A (NZ)
Title: Treatment of excessive osteolysis with indolinone compounds
Inventor: MURRAY LESLEY
IPC: A61K31/40
Filed: 2004-02-23
Abstract: Disclosed herein is the use of a compound of formula (I) in the manufacture of a medicament for treating excessive osteolysis, by inhibiting M-CSF mediated osteoclast development. These compounds also are useful for inhibiting phosphorylation of CSF1R, and for treating cancers that express CSF1R.